We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Novel Inflator Suitable for Multiple Interventional Balloon Systems

By HospiMedica International staff writers
Posted on 15 Jul 2013
A novel high-pressure syringe for use in catheterization laboratories could potentially replace multiple inflation systems by offering a wide range of available pressure.

The basixTOUCH high-pressure balloon inflator delivers pressure of up to 3546 kPa (or 35 atmospheres) for inflating an angioplasty balloon or other interventional device, continuously measuring the pressure within the balloon. More...
Once the intervention has ended, the balloon can be quickly deflated, dropping the pressure rapidly thanks to a quick-release handle. The system can be prepped and primed single-handedly, and eliminates the need to use multiple inflation devices in some advanced interventional cases, thanks to its high-pressure range.

Two important features of the device include an ergonomic handle and threads that ensure high pressures can be reached rapidly, reaching maximum with less than three clockwise rotations of the handle. The system is supplied with a 30 mL syringe barrel that accommodates additional fluid for large balloons. The basixTOUCH high-pressure balloon inflator is a product of Merit Medical (South Jordan, UT, USA), and has been approved by the US Food and Drug Administration (FDA).

“We believe the introduction of the basixTOUCH clearly places Merit in the worldwide leadership position for inflation devices which are used in numerous interventional and peripheral procedures,” said Fred Lampropoulos, chairman and CEO of Merit Medical. “This device and its derivatives have the potential, when combined with other devices such as our hemostasis valves, to become the largest single revenue producing product in Merit’s history.”

Related Links:
Merit Medical



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.